Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 8.10
-0.37 (-4.37%)
Oct 8, 2026, 2:27 PM CST
Holy Stone Healthcare Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.18B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 118.77M | -118.12M | -49.86% |
| Dec 31, 2023 | 236.89M | -33.35M | -12.34% |
| Dec 31, 2022 | 270.24M | 53.16M | 24.49% |
| Dec 31, 2021 | 217.08M | -4.51M | -2.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Level Biotechnology | 709.37M |
| Meribank Biotech | 408.48M |
| Abnova (Taiwan) | 345.45M |
| NeoCore Technology | 277.54M |
| TCI GENE | 251.39M |
| GeneReach Biotechnology | 238.08M |
| Enimmune | 53.45M |